We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Additional Remarks definition

Additional Remarks. REFERRING BROKER: RECIPIENT BROKER:
Sample 1Sample 2Sample 3
Additional Remarks. This Patent License Agreement, hereinafter referred to as the "
Sample 1
Additional Remarks. The terms of this AGREEMENT shall be considered CONFIDENTIAL. Public Benefit(s): The principal benefit of this invention is its potential to treat diseases of hormonal or endocrine tissues. This exclusive patent license agreement (hereinafter referred to as the ("AGREEMENT"), made effective the first date upon which all the Parties have subscribed their signatures hereunto ("EFFECTIVE DATE"), consists of this Cover Page, an attached AGREEMENT, a Signature Page, Appendix A (List of Patent(s) and/or Patent Application(s)), Appendix B (LICENSED FIELDS-OF-USE and LICENSED TERRITORY), Appendix C (Royalties), Appendix D (Modifications), Appendix E (BENCHMARKS), and Appendix F (COMMERCIAL DEVELOPMENT PLAN). The Parties to this AGREEMENT are:
Sample 1

Examples of Additional Remarks in a sentence

  • Before printing the BL verify that s “AUTHORIZED 0058 MOVE” is in the extra pickup address and that one of the fourteen statements has been annotated in the Special Remarks or in the Additional Remarks Sections.

  • Section III – Lease Terms Blocks 14 – 21: Enter information regarding Initial Lease Terms and Renewal Options of any Alternate Proposals, Schedule B lump sum costs, Rentable Square Foot Rate and Square Footage, Lists of Attachments, and any Additional Remarks, List of Attachments, Alternates, and any Additional Remarks.

  • Section III – Lease Terms Blocks 14 – 19: Enter information regarding Initial Lease Terms and Renewal Options of any Alternate Proposals, Schedule B lump sum costs, Rentable Square Foot Rate and Square Footage, Lists of Attachments, and any Additional Remarks, List of Attachments, Alternates, and any Additional Remarks.

  • The proponents consulted the IUCN Shark Specialist Group, academic experts, and various NGOs. The proponents also consulted the nomenclature specialist of the Animals Committee for review, and for his input on the nomenclatural aspects of this proposal (see Section 11, Additional Remarks, below).

  • Additional Remarks:  It is planned to check the introduction of the Customer/Vendor Integration in the pre-checks and the technical Conversion procedure of SAP S/4HANA, on-premise edition 1511.

  • If this activation has been announced by a NOTAM, the AMC reproduces the NOTAM reference in the Additional Remarks field of the AUP/UUPs. This adds to the com- pleteness of the AUP/UUPs for the whole of the FIR.

  • Additional Remarks Mr. Coleman stated that the BWROG (and rest of industry) needs to meet with the NRC to discuss compliance with Regulatory Guide 1.200, Revision 2.

  • If you could not record a highway contract route number during the reading, or if you discover after the reading that you recorded the wrong code, enter the proper code and proceed to the Additional Remarks field.

  • Additional Remarks, if any:The component – I will provide the necessary background to the concepts of quality specialization.

  • Additional Remarks (Applicant may mention here any additional qualification, experience including that of Computer knowledge, which have not been included under the heads given above) 15.


More Definitions of Additional Remarks

Additional Remarks. (1) For U.S. Patent No. 5,366,977, entitled "Methods of Treating Cystic Fibrosis Using 8-Cyclopentyl-1,3-Dipropylxanthine or Xanthine Amino Congeners": exclusively for the treatment of cystic fibrosis and (2) For U.S. Patent Application Serial No. 08/343,714, filed November 22, 1994, entitled "A Method of Identifying CFTR-Binding Compounds Useful for Activating Chloride Conductance in Animal Cells": (i) exclusively for the treatment and diagnosis of cystic fibrosis in humans; (ii) exclusively for the class of compounds claimed for therapeutic and diagnostic uses for human diseases other than cystic fibrosis conditionally for a period of twenty-four (24) months; and (iii) nonexclusively for methods for identifying CFTR-binding compounds. This Patent License Agreement, hereinafter referred to as the "Agreement," consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), Appendix E (Benchmarks), and Appendix F (Commercial Development Plan). The Parties to this Agreement are:
Sample 1
Additional Remarks. (please provide any additional information that may help in processing your request)
Sample 1

Related to Additional Remarks

  • Final Remarketing means any Remarketing of the Notes that occurs during the Final Remarketing Period by the Remarketing Agent(s) pursuant to the Remarketing Agreement.

  • Reference Interest Rate Transition Event means the occurrence of one or more of the following events with respect to the then-current Reference Interest Rate:

  • Failed Remarketing means, with respect to any reset date for a class of reset rate notes, the situation where: • the remarketing agent, in consultation with the administrator, cannot establish one or more of the terms required to be set on the Remarketing Terms Determination Date, • the remarketing agent is unable to establish the related Spread or fixed rate on the Spread Determination Date, • the remarketing agent is unable to remarket some or all of the tendered reset rate notes at the Spread or fixed rate established on the Spread Determination Date, or committed purchasers default on their purchase obligations, and the remarketing agent, in its sole discretion, elects not to purchase the applicable reset rate notes themselves, • the remarketing agent, in consultation with the administrator, is unable to obtain one or more swap agreements meeting the required criteria, if applicable, • certain conditions specified in the remarketing agreement are not satisfied, or • any applicable Rating Agency Condition has not been satisfied.

  • Successful Remarketing means, as applicable, a Successful Optional Remarketing or a Successful Final Remarketing.

  • Failed Remarketing Condition means a Failed Remarketing Condition-Purchased VRDP Shares or a Failed Remarketing Condition-Unpurchased VRDP Shares.

  • Accumulation Period Length means 12 months; provided, however, if the commencement of the Accumulation Period is delayed in accordance with Section 2.11 hereof, the Accumulation Period Length shall be determined in accordance with the definition of “Accumulation Period Length” in the Indenture Supplement.

  • Interest Payment Determination Date means the date two U.S. Government Securities Business Days before each Interest Payment Date.

  • Payment Determination Date means, with respect to any Payment Date, one (1) Business Day immediately preceding such Payment Date.

  • Tax Event Repayment Date means the date set out in a notice from the Issuer to the Bondholders pursuant to Clause 10.4 (Early redemption option due to a tax event).

  • Early Amortization Event means the occurrence of any of the following:

  • Liquidity Provider Ratings Event Termination Date means the date established by the Tender and Paying Agent, acting upon instructions of the Fund pursuant to the Tender and Paying Agent Agreement, for termination of the VRDP Purchase Agreement upon the occurrence of a Liquidity Provider Ratings Event, which date shall be not less than 16 days nor more than 30 days following such Liquidity Provider Ratings Event.

  • Monthly Report Determination Date The meaning specified in Section 10.7(a).

  • Event Determination Date means either:

  • Non-Lead Securitization Determination Date means the “determination date” (or any term substantially similar thereto) as defined in the related Non-Lead Securitization Servicing Agreement.

  • Fixed Rate Period Remaining Life means, with respect to any Debenture, the period from the Special Redemption Date for such Debenture to the Interest Payment Date in December 2010.

  • Administrator/Benchmark Event Determination Date means, in relation to any Index, the date on which the Calculation Agent determines that an Administrator/Benchmark Event has occurred;

  • Periodic Term SOFR Determination Day has the meaning specified in the definition of “Term SOFR”.

  • Interest Rate Determination Date means, with respect to any Interest Period, the date that is two Business Days prior to the first day of such Interest Period.

  • Interest Determination Date means, with respect to a Rate of Interest and Interest Accrual Period, the date specified as such hereon or, if none is so specified, (i) the first day of such Interest Accrual Period if the Specified Currency is Sterling or (ii) the day falling two Business Days in London for the Specified Currency prior to the first day of such Interest Accrual Period if the Specified Currency is neither Sterling nor euro or (iii) the day falling two TARGET Business Days prior to the first day of such Interest Accrual Period if the Specified Currency is euro.

  • Termination Fee Event has the meaning ascribed thereto in Section 5.2(a);

  • Extension Determination Date means, in respect of a Series of Covered Bonds, the date falling two Business Days after the expiry of seven days from (and including) the Final Maturity Date of such Covered Bonds.

  • Controlled Accumulation Period Length has the meaning specified in subsection 4.03(c).

  • Accretion Termination Date As defined in the Series Supplement.

  • Reset Interest Determination Date means, in respect of any Reset Period, the day falling two Business Days prior to the beginning of the relevant Reset Period;

  • SOFR Interest Determination Date means the day that is the number of U.S. Government Securities Business Days prior to the Interest Payment Date in respect of the relevant Interest Period, as specified in the applicable Pricing Supplement.

  • Subsequent Rate Period means, with respect to any Series of RVMTP Shares, the period consisting of seven calendar days, but adjusted in each case to reflect any changes when the regular calendar day that is a Rate Determination Date is not a Business Day, from, and including, the first calendar day following the Initial Rate Period of such Series to, and including, the next Rate Determination Date for such Series and any period thereafter from, and including, the first calendar day following a Rate Determination Date for shares of such Series to, and including, the next succeeding Rate Determination Date for shares of such Series.

Most Referenced Clauses

Most Referenced Definitions